Clinical trials · Pittsburgh, PA
Sickle Cell Anemia clinical trials in Pittsburgh
We’re tracking 3 recruiting sickle cell anemia studies with a site in or near Pittsburgh — including Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Pittsburgh
- NCT03653338RecruitingPhase 1/Phase 2
Bone marrow transplant using donor blood to treat sickle cell
This trial tests a specific type of bone marrow transplant for people with sickle cell disease (or certain other blood disorders) who have had serious complications despite standard care. It aims to see if removing the patient’s immune cells and using a matched donor’s cells can improve outcomes and reduce complications.
Pittsburgh, PennsylvaniaAges 5–40 - NCT06481306RecruitingPhase 1/Phase 2
Testing a new drug for sickle cell disease in healthy people and patients
This early-phase study tests a new drug (BMS-986470) for people with sickle cell disease who have frequent pain crises. The goal is to see if it can safely reduce crises. It includes a small group of healthy volunteers as well.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT04109820Recruiting
Testing MitoQ for blood clotting activity in sickle cell
This trial studies whether MitoQ changes how your platelets (blood cells that help clot) work and how much “reactive oxygen” your body makes. It includes adults with sickle cell anemia and African American healthy volunteers to compare results.
Pittsburgh, PennsylvaniaAges 18 years+
Hear when a new Sickle Cell Anemia trial opens near Pittsburgh, PA
We’ll email you when one opens near Pittsburgh, PA — at most once a week, no account needed, unsubscribe anytime.
Sickle Cell Anemia trials in other cities
Where these studies are running near Pittsburgh
Institutions with a site for the recruiting sickle cell anemia studies listed above.
- UPMC Children's Hospital of Pittsburgh · 2 studies
- Local Institution - 0032
- Magee-Womens Hospital of UPMC
- UPMC Hillman Cancer Center
- UPMC Montefiore Hospital
- UPMC Presbyterian Hospital
What taking part in a sickle cell anemia study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting sickle cell anemia studies in Pennsylvania.
Common questions
- Are there sickle cell anemia clinical trials near Pittsburgh?
- Yes. We're currently tracking 3 recruiting sickle cell anemia studies with a site near Pittsburgh, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a sickle cell anemia study near Pittsburgh?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Pittsburgh to take part?
- Not necessarily. These studies have a site near Pittsburgh, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a sickle cell anemia trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New sickle cell anemia studies open near Pittsburgh regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.